Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,649 | 4,457 | 4,573 | 4,172 | 3,142 |
| Operating Income | -2,649 | -4,457 | -4,573 | -4,172 | -3,142 |
| Other Income | -327 | -772 | 40 | 41 | 73 |
| Pre-tax Income | -2,975 | -5,229 | -4,532 | -4,131 | -3,069 |
| Net Income Continuous | -2,975 | -5,229 | -4,532 | -4,131 | -3,069 |
| Net Income | $-2,975 | $-5,229 | $-4,532 | $-4,131 | $-3,069 |
| EPS Basic Total Ops | -2.98 | -9.09 | -8.96 | -10.29 | -9.04 |
| EPS Basic Continuous Ops | -2.98 | -9.10 | -9.00 | -10.15 | -9.04 |
| EPS Diluted Total Ops | -2.98 | -9.09 | -8.96 | -10.29 | -9.04 |
| EPS Diluted Continuous Ops | -2.98 | -9.10 | -9.00 | -10.15 | -9.04 |
| EPS Diluted Before Non-Recurring Items | -2.98 | -9.09 | -8.96 | -10.64 | -8.96 |
| EBITDA(a) | $-2,649 | $-4,457 | $-4,573 | $-4,172 | $-3,142 |